BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7877355)

  • 1. [The seroprevalence of antibodies against Lyme borreliosis in a healthy population on the Island of Lanzarote, Spain].
    Carranza R; Borobio MV; Pascual F; Perea EJ
    Med Clin (Barc); 1995 Jan; 104(1):38. PubMed ID: 7877355
    [No Abstract]   [Full Text] [Related]  

  • 2. Epidemiology and prevalence of seropositivity against Borrelia burgdorferi antigen in La Rioja, Spain.
    Oteo JA; Martinez de Artola V; Casas J; Lozano A; Fernandez Calvo JL; Grandival R
    Rev Epidemiol Sante Publique; 1992; 40(2):85-92. PubMed ID: 1631381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tick-borne borreliosis in the archipelago of southern Sweden.
    Berglund J; Eitrem R
    Scand J Infect Dis; 1993; 25(1):67-72. PubMed ID: 8460352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The epidemiological aspects of Lyme borreliosis in Sverdlovsk Province].
    Lesniak OM; Ponomarev DN; Volkova LI; Il'ina NS; Laĭkovskaia EE; Dvoskina BIa
    Med Parazitol (Mosk); 1995; (1):7-10. PubMed ID: 7770026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevalence of antibodies against Borrelia burgdorferi among the population of Seville].
    López Prieto MD; Borobio MV
    Enferm Infecc Microbiol Clin; 1989 Nov; 7(9):489-90. PubMed ID: 2490479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Lyme disease in the province of Soria: clinico-epidemiologic study].
    Saz JV; Nuncio S; Merino FJ; Aquise M; Medina J; Filipe AR
    Enferm Infecc Microbiol Clin; 1994 Feb; 12(2):52-9. PubMed ID: 8011711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibodies against Borrelia burgdorferi in a population group from Valladolid].
    Tamayo L; García-Moncó JC; Bratos MA; Orduña A; Ortiz de Lejarazu R; Rodríguez Torres A
    Enferm Infecc Microbiol Clin; 1990 Dec; 8(10):663-4. PubMed ID: 2098134
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prevalence of Borrelia burgdorferi antibodies in a population at risk].
    Oteo JA; Martínez de Artola V; Fernández Calvo JL; Casas JM; Rivero A; Grandival R
    Rev Clin Esp; 1990 Oct; 187(5):215-7. PubMed ID: 2102530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiologic, ecologic and clinical characteristics of Lyme borrelliosis in northwest Croatia.
    Golubić D; Rijpkema S; Tkalec-Makovec N; Ruzić E
    Acta Med Croatica; 1998; 52(1):7-13. PubMed ID: 9599811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Lyme disease in Tunisia, results of a clinical and serological study (1992-1996)].
    Aoun K; Kechrid A; Lagha N; Zarrouk A; Bouzouaia N
    Sante; 1998; 8(2):98-100. PubMed ID: 9642728
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Frequency of lyme borreliosis and diagnostic titers of antibodies to borrelia burgdorferi in patients with neurological diseases in endemic region of Russia].
    Il'ina NS; Lesniak OM; Volkova LI; Turova EL; Sokolova ZI; Laikovskaia EE
    Klin Med (Mosk); 1996; 74(4):39-42. PubMed ID: 8999151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver changes and positive serology against Borrelia burgdorferi].
    Saz JV; Nuncio S; Merino FJ; Aquise M
    Med Clin (Barc); 1994 May; 102(18):716-7. PubMed ID: 8028426
    [No Abstract]   [Full Text] [Related]  

  • 13. [The incidence of Lyme arthritis and of antibodies to Borrelia burgdorferi in rheumatology patients in an endemic area].
    Lesniak OM; Sokolova ZI; Laĭkovskaia EE; Riabitseva OF
    Ter Arkh; 1994; 66(5):45-7. PubMed ID: 7940338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lyme borreliosis: how is it manifested in Spain?].
    Guerrero A; Quereda C; Martí-Belda P; Escudero R
    Med Clin (Barc); 1993 May; 101(1):5-7. PubMed ID: 8315978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Borrelia burgdorferi seropositivity in the region of Cacak].
    Antonijević B; Luković M; Stanojević A; Zivković-Lesić Lj
    Glas Srp Akad Nauka Med; 1993; (43):77-80. PubMed ID: 8262428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The experience of a serological examination of the rural population in a territory endemic for Lyme borreliosis].
    Korenberg EI; Kalinin MI; Skripnikova IA; Soldatkina LM
    Med Parazitol (Mosk); 1990; (3):15-6. PubMed ID: 2145501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Risk factors associated with the presence of antibodies against Borrelia burgdorferi].
    Arteaga Pérez F; García-Moncó Carra JC
    Rev Clin Esp; 1999 Mar; 199(3):136-41. PubMed ID: 10230291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lyme borreliosis in Spain: a serological survey.
    Guerrero A; Escudero R; Martí-Belda P; Quereda C; Miramón J
    Clin Infect Dis; 1994 Mar; 18(3):493-4. PubMed ID: 8011855
    [No Abstract]   [Full Text] [Related]  

  • 19. [Detection of Borrelia burgdorferi antibodies in a population sample of the state of Zulia].
    Arocha-Sandoval F; Amesty-Valbuena A; Urbina M; Durango AI; Vargas-Montiel H
    Invest Clin; 1994 Jun; 35(2):91-104. PubMed ID: 7918761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Are seroprevalence studies useful in Lyme disease?].
    Díaz-Míguez D; Fernández-Fernández F; Sesma P; Rodríguez-Mayo MD
    Enferm Infecc Microbiol Clin; 1993 Oct; 11(8):460-1. PubMed ID: 8260522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.